TriangleHEALTH PROFESSIONAL · SOURCE READING
Maxillary Sinus Tumors
Source: Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: July 5, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Stage IV Paranasal Sinus and Nasal Cavity Cancer
Treatment options for stage IV maxillary sinus tumors include the following:
High-dose radiation therapy is used because extension to the base of the skull and nasopharynx is a potential, but not absolute, contraindication to surgery. If radiation therapy is to be used alone, localized drainage of the sinus(es) must be established before radiation therapy treatments are initiated.
Superfractionated radiation therapy (under clinical evaluation).[1]
Source links and citations
Clinical trials for advanced tumors should be considered to evaluate chemotherapy preoperatively or before radiation therapy. Adjuvant therapy after surgery or after combined-modality therapy should also be considered.
Concurrent chemotherapy and radiation therapy may be considered.
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice